Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mutaz, Nur"'
Autor:
Elhassadi, Ezzat, Hennessy, Brian, Kumar, Senthil, Sutton, Louise, Mutaz, Nur, Shatwan, Ramadan, Quinn, Anne, Catherwood, Mark, Hayat, Amjad
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S513-S514
Autor:
Elhassadi, Ezzat, Hennessy, Brian, Kumar, Senthil, Sutton, Louise, Mutaz, Nur, Shatwan, Ramadan, Quinn, Anne, Catherwood, Mark, Hayat, Amjad
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S227-S227
Autor:
Mutaz Nur, Senthil Kumar, Laura McDonald, Louise Sutton, Fiona Lynott, Michelle Griffin, Brian Hennessy, Megan Shum, Aisha Mohamed, Ezzat Elhassadi
Publikováno v:
Blood. 138:4465-4465
Introduction: Acute myeloid leukaemia (AML) is a heterogeneous disorder that arises from clonal expansion of malignant hematopoietic precursor cells. Somatic mutations of the p53 gene have been reported in 5-10% of AML, with a higher incidence therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55842153ac37e3b0a1dabc1d6d8d7c45
https://doi.org/10.1182/blood-2021-149262
https://doi.org/10.1182/blood-2021-149262
Autor:
Eimear Lee, Mutaz Nur, Louise Sutton, Michelle Griffin, Christine Schilling, Senthil Kumar, Ezzat Elhassadi, Mark Catherwood, Amjad Hayat, Brian Hennessy, Osasere Osarhieme, Anne Marie Quinn, Ramadan Shatwan, Rehman Faryal
Publikováno v:
Blood. 138:4514-4514
Background: MCL is a rare type of non-Hodgkin lymphoma (NHL) with an aggressive clinical course. MCL is associated with poor prognosis and incurable disease in the majority of patients. However, a minority of patients will not require any treatment f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc20aac28dcecaf4c597181b8278aa29
https://doi.org/10.1182/blood-2021-149653
https://doi.org/10.1182/blood-2021-149653
Publikováno v:
Lung Cancer. 156:S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e08704d360ac6179382a9a2879b724f
https://doi.org/10.1016/s0169-5002(21)00202-6
https://doi.org/10.1016/s0169-5002(21)00202-6
Autor:
Ezzat El Hassadi, Senthil Kumar, Brian Hennessy, Mutaz Nur, Christine Schilling, Laura McDonald
Publikováno v:
Blood. 136:29-30
Introduction Acute myeloid leukaemia (AML) is a heterogenous disorder that arises from clonal expansion of malignant hematopoietic precursor cells. The tumor suppressor p53 gene plays an important role in regulation of the cell cycle and apoptosis. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::721ab1051561878e38b9d7ff7866837d
https://doi.org/10.1182/blood-2020-140920
https://doi.org/10.1182/blood-2020-140920
Autor:
Nemer Osman, John V. Reynolds, Yasir Y. Elamin, Shereen Rafee, Cian Muldoon, Mutaz Nur, Kenneth J. O'Byrne
Publikováno v:
International Journal of Cancer and Clinical Research. 1
Background: Trastuzumab has been approved for patients with human epidermal growth factor receptor 2 (HER2) over expression and gene amplification metastatic gastric cancer. Here we present the prevalence of HER2 positive gastric cancer in an Irish p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc147536a85437c64137680875e68a3
https://doi.org/10.23937/2378-3419/1/1/1008
https://doi.org/10.23937/2378-3419/1/1/1008
Publikováno v:
Expert review of anticancer therapy. 14(3)
Evaluation of: Maurer J, Schopp M, Thurau K et al. Immunohistochemical analysis on potential new molecular targets for esophageal cancer. Dis. Esophagus 27(1), 93–100 (2014).Targeting specific molecules and their associated molecular pathways in ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4dcc5291fe69d5a0f9308cca944b697
https://pubmed.ncbi.nlm.nih.gov/23551625
https://pubmed.ncbi.nlm.nih.gov/23551625